The deepening gap between the potential clinical utility of the Ki67 LI and availability of robust measurement methodologies is reflected by the St Gallen 2013 consensus[21]: while the cut off <14% remains in the definition of the Luminal A-like tumours, a majority voted for the threshold of ≥20% to define “high” Ki67 status. Here, MKI67 is linked to neoplasm.